Associated Papers
Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National LIPIGEN Registry.
D'Erasmo L et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2025
41099101 (PubMed )
Supplement: atv-45-2264-s001.pdf
The Ongoing Utility of lipoprotein lipase activity in diagnosing familial Chylomicronemia Syndrome.
Fariña G et al.
Biochemistry and Biophysics Reports, 2025
Genetic variation in apolipoprotein A-V in hypertriglyceridemia.
Perera SD et al.
Current Opinion in Lipidology, 2024
Role of glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in hypertriglyceridemia and diabetes.
Kurooka N et al.
Journal of Diabetes Investigation, 2023
Analyses of familial chylomicronemia syndrome in Pereira, Colombia 2010-2020: a cross-sectional study.
Rodriguez FH et al.
Lipids in Health and Disease, 2023
Global genetic diversity of human apolipoproteins and effects on cardiovascular disease risk.
Zhou Y et al.
Journal of Lipid Research, 2018
30076208 (PubMed )
Supplement: 10.1194_P086710_jlr.P086710-4.xlsx › Other_APO_genes
Genetic variants in triglyceride metabolism genes among individuals with hypertriglyceridemia in Colombia.
Puerto-Baracaldo K et al.
Journal of Clinical Lipidology, 0
Familial chylomicronemia syndrome caused by 2 genetic variants in the APOA5 gene: Severe hypertriglyceridemia that complicates pregnancy.
Gutiérrez J et al.
Journal of Clinical Lipidology, 0
Select a paper to view details